▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1439 by analyst upside · 2026-06-27
IRWD
Ironwood Pharmaceuticals, Inc.
Healthcare · Market Cap $680M · P/E 6.3x
ANALYST PRICE TARGET
+47.7%
implied upside to consensus target
Current Price $4.13
Consensus Target $6.1
Bull Target $10.0
Bear Target $3.7
Analysts Covering 4
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
1
Hold
2
Sell
0
52-Week Low $0.67
52-Week High $5.78
YTD Return -3.3%
FUNDAMENTALS
Market Cap $680M
P/E Ratio (TTM) 6.3x
Forward P/E 2.9x
EPS (TTM) $0.66
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $362M
Profit Margin 28.3%
52-WEEK RANGE
52-Week Low $0.67
52-Week High $5.78
Current Price $4.13
Bear Target $3.7
Bull Target $10.0
● Now $4.13 ● Target $6.1
TRADING DATA
Avg Volume 2.2M
YTD Return -3.3%
Analyst Count 4
Consensus Buy
Upside to Target +47.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Ironwood Pharmaceuticals, Inc. (IRWD) is currently trading at $4.13 with a Wall Street consensus price target of $6.1, implying potential upside of 47.7% over the next 12 months. 4 analysts currently cover IRWD, with a consensus rating of Buy — 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.0, while the most cautious has a target of $3.7.

IRWD operates in the Healthcare sector with a market capitalisation of $680M. The stock is down 3.3% year-to-date and is currently trading near the upper end of its 52-week range of $0.67 – $5.78.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RIGL +40.1%
Rigel Pharmaceuticals, Inc.
$716M · P/E 2.0x · Buy
BVS +51.3%
Bioventus Inc.
$663M · P/E 23.9x · Buy
GMRS +33.3%
GMR Solutions Inc.
$785M · P/E 7.6x · Buy
MDXG +65.4%
MiMedx Group, Inc.
$585M · P/E 19.6x · Buy
TCMD +30.4%
Tactile Systems Technology, Inc.
$683M · P/E 32.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for IRWD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citizens — Reiterated
Market Outperform → Market Outperform 2026-02-26 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-01-05 Building track record
Citizens ↑ Upgrade
Market Perform → Market Outperform 2026-01-05 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2025-11-11 Building track record
Wells Fargo ↓ Downgrade
Overweight → Equal-Weight 2025-04-15 Building track record
Jefferies ↓ Downgrade
Buy → Hold 2025-04-15 50% win rate (6 calls)
Leerink Partners — Reiterated
Market Perform → Market Perform 2025-04-14 29% win rate (7 calls)
JMP Securities — Reiterated
Market Outperform → Market Outperform 2025-01-30 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →